S230. LONG-TERM ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA: BENEFITS, RISKS AND FOLLOW-UP: DATA FROM FINNISH COHORT STUDIES AND SYSTEMATIC REVIEW

BACKGROUND: Millions of people use antipsychotic medications. Thousands of clinicians (often non-psychiatrists) prescribe and monitor them every day. Existing research reports mostly favorable risk-benefit ratio during the first years of schizophrenia, but their risk-benefit ratio and maintenance ef...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Schizophr Bull
Главные авторы: Isohanni, Matti, Miettunen, Jouko, Jääskeläinen, Erika, Moilanen, Jani, Hulkko, Anja, Huhtaniska, Sanna
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2018
Предметы:
Abstracts
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5888038/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby018.1017
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы